Animalcare Group PLC
LSE:ANCR

Watchlist Manager
Animalcare Group PLC Logo
Animalcare Group PLC
LSE:ANCR
Watchlist
Price: 238 GBX -0.83% Market Closed
Market Cap: 164.2m GBX
Have any thoughts about
Animalcare Group PLC?
Write Note

Animalcare Group PLC
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Animalcare Group PLC
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Animalcare Group PLC
LSE:ANCR
Cash & Cash Equivalents
ÂŁ34.8m
CAGR 3-Years
97%
CAGR 5-Years
55%
CAGR 10-Years
25%
GlaxoSmithKline PLC
LSE:GSK
Cash & Cash Equivalents
ÂŁ3B
CAGR 3-Years
-5%
CAGR 5-Years
-6%
CAGR 10-Years
-1%
AstraZeneca PLC
LSE:AZN
Cash & Cash Equivalents
$6.9B
CAGR 3-Years
-24%
CAGR 5-Years
5%
CAGR 10-Years
3%
Verona Pharma PLC
NASDAQ:VRNA
Cash & Cash Equivalents
$336m
CAGR 3-Years
26%
CAGR 5-Years
52%
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Cash & Cash Equivalents
$133m
CAGR 3-Years
-18%
CAGR 5-Years
-16%
CAGR 10-Years
-7%
Dechra Pharmaceuticals PLC
LSE:DPH
Cash & Cash Equivalents
ÂŁ74.4m
CAGR 3-Years
-31%
CAGR 5-Years
-1%
CAGR 10-Years
9%
No Stocks Found

Animalcare Group PLC
Glance View

Market Cap
164.2m GBX
Industry
Pharmaceuticals

Animalcare Group Plc engages in the development, sale, and supply of generic veterinary medicines and animal identification products. The company is headquartered in Ripon, North Yorkshire. The company went IPO on 2008-01-15. The firm is focused on developing and commercializing prescription and over-the-counter pharmaceutical products. The firm operates in three categories within the veterinary market, which includes Companion Animals, Equine and Production Animals. The company manages international supply chain, including specialist veterinary wholesalers and distributors. The firm develops, supplies and markets products and services to the veterinary profession. The company focuses on therapeutic areas, which includes pain management, dermatology and anti-infectives. The Company’s product pipeline is Daxocox, which is a differentiated COX-2 inhibitor for the treatment of chronic pain in dogs.

ANCR Intrinsic Value
336.99 GBX
Undervaluation 29%
Intrinsic Value
Price

See Also

What is Animalcare Group PLC's Cash & Cash Equivalents?
Cash & Cash Equivalents
34.8m GBP

Based on the financial report for Jun 30, 2024, Animalcare Group PLC's Cash & Cash Equivalents amounts to 34.8m GBP.

What is Animalcare Group PLC's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
25%

Over the last year, the Cash & Cash Equivalents growth was 427%. The average annual Cash & Cash Equivalents growth rates for Animalcare Group PLC have been 97% over the past three years , 55% over the past five years , and 25% over the past ten years .

Back to Top